Prognostic factors for breast cancer squamous cell carcinoma and nomogram development for prediction: population-based research

被引:2
作者
Cheng, Zhiyuan [1 ]
Han, Tao [2 ]
Zhang, Xiaotian [1 ]
Li, Xizhou [1 ]
Li, Hengyu [3 ]
Gu, Jia [4 ]
机构
[1] Navy Med Univ, Coll Basic Med Sci, Shanghai 200433, Peoples R China
[2] Gen Hosp Northern Theater Command, Dept Oncol, Shenyang 110011, Liaoning, Peoples R China
[3] Navy Med Univ, Changhai Hosp, Dept Thyroid & Breast Surg, Shanghai 200433, Peoples R China
[4] China Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Shenyang 110001, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast squamous cell carcinoma (BSqCC); nomogram; prognosis analysis; the Surveillance; Epidemiology; End Results (SEER) database; ABSCESS;
D O I
10.21037/tcr.2019.09.13
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To investigate the prognostic survival factors of breast squamous cell carcinoma (BSqCC) and develop a comprehensive nomogram for predicting the survival of breast cancer squamous cell carcinoma. Methods: Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) database to identify patients diagnosed with BSqCC from 1973 to 2015. The data was obtained using SEER Stat 8.3.4 software, collated, and analyzed by Excel 2016 software and SPSS (v25.0). Kaplan-Meier curves were used for survival analysis. The variables obtained by univariate analysis were introduced into the Cox proportional hazard model for multivariate analysis. The risk factors affecting the prognosis of BSqCC were obtained. P<0.05 was considered statistically significant. The independent prognostic factors of BSqCC were integrated and used to construct nomograms. Results: A total of 739 patients with BSqCC was included. The median age of diagnosis was 66 years. In most cases, the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) was negative. One-third of the cases underwent breast-conserving surgery, and more than half of the cases underwent mastectomy (unilateral or bilateral). The 1-year survival rate was 81.2%, the 3-year survival rate was 62.9%, the 5-year survival rate was 54.4%, and the 10-year survival rate was 41.4%. Age (chi(2) =71.050, P<0.001), marital status (chi(2) =37.560, P<0.001), tumor size (chi(2) =27.931, P<0.001), surgical procedure (chi(2) =74.185, P<0.001), the number of positive lymph nodes (chi(2) =38.542, P<0.001), and the primary site (chi(2) =59.217, P<0.001) were significantly correlated with patient survival time. Among them, marital status (HR: 0.502, 95% CI: 0.318-0.794), age (HR: 2.186, 95% CI: 1.234-3.875), surgical procedure (HR: 1.03, 95% CI: 1.01-1.051), tumor size (HR: 1.505, 95% CI: 1.083-2.091) and the number of positive lymph nodes (HR: 1.277, 95% CI: 1.087-1.499) were independent risk factors for the survival of BSqCC. Five independent prognostic factors were then integrated for the construction of nomograms. Conclusions: BSqCC was a malignant tumor with a low survival rate. Age of onset was typically at an older age; mostly middle-aged and seniors. Marital status, age, surgical procedure, tumor size, and several positive lymph nodes were independent predictors of patient survival. At the same time, we developed a prognostic nomogram with excellent discrimination for breast cancer squamous cell carcinoma; therefore, it could help clinicians make decisions on a personal basis.
引用
收藏
页码:2014 / 2023
页数:10
相关论文
共 25 条
[1]   A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy [J].
Alan, Ozkan ;
Telli, Tugba Akin ;
Ercelep, Ozlem ;
Hasanov, Rahib ;
Simsek, Eda Tanrikulu ;
Mutis, Aydan ;
Ones, Tunc ;
Kaya, Handan ;
Yumuk, Perran Fulden .
CURRENT PROBLEMS IN CANCER, 2019, 43 (04) :308-311
[2]   Squamous cell carcinoma of the breast [J].
Aparicio, I. ;
Martinez, A. ;
Hernandez, G. ;
Hardisson, D. ;
De Santiago, J. .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 137 (02) :222-226
[3]  
Badge Sachin A, 2014, Int J Appl Basic Med Res, V4, P53, DOI 10.4103/2229-516X.125697
[4]   Squamous cell carcinoma of the breast: clinico-pathologic implications and outcome [J].
Behranwala, KA ;
Nasiri, N ;
Abdullah, N ;
Trott, PA ;
Gui, GPH .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (04) :386-389
[5]   Management and prognosis of pure primary squamous cell carcinoma of the breast [J].
Benoist, P. ;
Mureau, A. ;
Joueidi, Y. ;
Arbion, F. ;
Vilde, A. ;
Body, G. ;
Michenet, P. ;
Leveque, J. ;
Ouldamer, L. .
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2018, 47 (07) :275-280
[6]   Breast Metaplastic Squamous Cell Carcinoma Diagnosed with Fine Needle and Core Biopsy: A Case Study [J].
Cha, Na ;
Wang, Shiyu ;
Lv, Ming ;
Wang, Dong-Wei ;
Zhang, Xiao-Jie ;
Zheng, Min ;
Tian, Li-Xiang .
AMERICAN JOURNAL OF CASE REPORTS, 2018, 19 :203-206
[7]   Primary epidermoid carcinoma of the breast presenting as a breast abscess and sepsis [J].
Damin, Andrea Pires ;
Nascimento, Fernanda Costa ;
Andreola, Joao Batista ;
Cerutti, Talita Haubert ;
Roehe, Adriana ;
Damin, Daniel Carvalho .
SAO PAULO MEDICAL JOURNAL, 2011, 129 (06) :424-427
[8]   Higher efficacy and complete response with administration of eribulin for recurrent squamous cell breast carcinoma: A case report [J].
Goto, Yoshinari ;
Yoshida, Takashi ;
Kimura, Morihiko .
MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (03) :318-320
[9]   Primary squamous cell carcinoma of the breast: Case report and management decisions [J].
Gupta, Nidhi ;
Vashisht, Rajesh ;
Nimbran, Vinod ;
Gupta, Rakesh ;
Dhingra, Neerja ;
Bhutani, Anjali .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (02) :323-325
[10]   Squamous cell carcinoma of the breast [J].
Hennessy, BT ;
Krishnamurthy, S ;
Giordano, S ;
Buchholz, TA ;
Kau, SW ;
Duan, ZG ;
Valero, V ;
Hortobagyi, GN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7827-7835